References
Ferrone ML, Raut CP (2012) Modern surgical therapy: limb salvage and the role of amputation for extremity soft-tissue sarcomas. Surg Oncol Clin N Am 21(2):201–213
von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S et al (2020) NCCN guidelines insights: soft tissue sarcoma, Version 1.2021. J Natl Compr Canc Netw 18(12):1604–12
Erstad DJ, Raut CP (2018) Amputation for sarcoma: revisiting a 19th century treatment in the 21st century. Ann Surg Oncol 25(2):351–353
Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196(3):305–315
Krikelis D, Judson I (2010) Role of chemotherapy in the management of soft tissue sarcomas. Expert Rev Anticancer Ther 10(2):249–260
Istl AC, Ruck JM, Morris CD, Levin AS, Meyer CF, Johnston FM (2019) Call for improved design and reporting in soft tissue sarcoma studies: a systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS. J Surg Oncol 119(7):824–835
Jakob J, Hohenberger P (2016) Role of isolated limb perfusion with recombinant human tumor necrosis factor alpha and melphalan in locally advanced extremity soft tissue sarcoma. Cancer 122(17):2624–2632
Cherix S, Speiser M, Matter M, Raffoul W, Lienard D, Theumann N et al (2008) Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients. J Surg Oncol 98(3):148–155
Verhoef C, de Wilt JH, Grunhagen DJ, van Geel AN, ten Hagen TL, Eggermont AM (2007) Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma. Curr Treat Options Oncol 8(6):417–427
Deneve JL, Zager JS (2012) Isolated regional therapy for advanced extremity soft tissue sarcomas. Surg Oncol Clin N Am 21(2):287–299
Lejeune FJ, Pujol N, Lienard D, Mosimann F, Raffoul W, Genton A et al (2000) Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Eur J Surg Oncol 26(7):669–678
Podleska LE, Poeppel T, Herbrik M, Dahlkamp L, Grabellus F, Taeger G (2014) Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation. World J Surg Oncol 12:81
Spacek M, Mitas P, Vocka M, Lacina L, Hodkova G, Spunda R, et al. (n.d) Isolated Perfusion of the Upper Extremity with TNF-alpha - Double Venous Cannulation. Klin Onkol.30(3):213–9.
Minor DR, Allen RE, Alberts D, Peng YM, Tardelli G, Hutchinson J (1985) A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer 55(11):2638–2644
Wieberdink J, Benckhuysen C, Braat RP, van Slooten EA, Olthuis GA (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18(10):905–910
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–47
Podleska LE, Kaya N, Farzaliyev F, Pottgen C, Bauer S, Taeger G (2017) Lower limb function and quality of life after ILP for soft-tissue sarcoma. World J Surg Oncol 15(1):84
Puhaindran ME, Steensma MR, Athanasian EA (2010) Partial hand preservation for large soft tissue sarcomas of the hand. J Hand Surg Am 35(2):291–295
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krishnan, C.K., Arivazhagan, P., Karnawat, A. et al. Isolated Limb Perfusion of Upper Limb: How I Do It. Indian J Surg Oncol 13, 776–779 (2022). https://doi.org/10.1007/s13193-022-01561-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-022-01561-3